Chemoinformaics analysis of 2(3H)-Furanone, 5-ethenyldihydro-5-methyl-
| Molecular Weight | 126.155 | nRot | 1 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 7 |
| Exact Molecular Weight | 126.068 | nRing | 1 |
| Solubility: LogS | -1.251 | nHRing | 1 |
| Solubility: LogP | 1.205 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 19.9619 |
| nHD | 0 | BPOL | 12.6361 |
| QED | 0.39 |
| Synth | 3.811 |
| Natural Product Likeliness | 3.019 |
| NR-PPAR-gamma | 0.08 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.413 |
| MDCK | 0.0000334 |
| BBB | 0.997 |
| PPB | 0.589775 |
| VDSS | 0.984 |
| FU | 0.602326 |
| CYP1A2-inh | 0.087 |
| CYP1A2-sub | 0.423 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.79 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.256 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.221 |
| CYP3a4-inh | 0.213 |
| CYP3a4-sub | 0.359 |
| CL | 6.946 |
| T12 | 0.835 |
| hERG | 0.013 |
| Ames | 0.026 |
| ROA | 0.206 |
| SkinSen | 0.793 |
| Carcinogencity | 0.637 |
| EI | 0.926 |
| Respiratory | 0.133 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.942151 |